OAS1 and Alzheimer disease: This study demonstrates that the presence of Aβ also causes an increase in endogenous dsRNA, which activates the OAS1 enzyme; therefore, the benefits of carrying the more effective OAS1 genetic variants against viral infection may also afford a protective moderator response to Aβ and consequently AD.